P/E ratio for InfuSystem (INFU)
P/E ratio as of April 2024 (TTM): 254
According to InfuSystem's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 253.667. At the end of 2022 the company had a P/E ratio of > 1000.
P/E ratio history for InfuSystem from 2007 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | > 1000 | 2.0567089402964E+18% |
| 2021 | 243 | 1027.04% |
| 2020 | 21.6 | -82.29% |
| 2019 | 122 | -277.12% |
| 2018 | -68.8 | 2652% |
| 2017 | -2.50 | -99.44% |
| 2016 | -447 | -2319.69% |
| 2015 | 20.1 | 2.26% |
| 2014 | 19.7 | -29.03% |
| 2013 | 27.7 | -226.63% |
| 2012 | -21.9 | 2839.04% |
| 2011 | -0.7454 | -97.12% |
| 2010 | -25.9 | -147.07% |
| 2009 | 55.0 | 1234.04% |
| 2008 | 4.12 | -114.9% |
| 2007 | -27.7 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Premier PINC | 13.5 | -94.67% | 🇺🇸 USA |
 DexCom DXCM | 141 | -44.48% | 🇺🇸 USA |
 CorVel Corporation
CRVL | 54.6 | -78.47% | 🇺🇸 USA |
 Biolase
BIOL | -0.0006 | -100.00% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.